Today: 29 June 2026
Browse Category

NASDAQ:AZN 1 October 2025 - 1 March 2026

Nasdaq Nordic Week Ahead: OMXS30 ends February at 3,222.75 as PMIs, inflation and U.S. jobs loom

Nasdaq Nordic Week Ahead: OMXS30 ends February at 3,222.75 as PMIs, inflation and U.S. jobs loom

Stockholm’s OMXS30 closed Friday up 0.55% at 3,222.75, hitting a record high, while the OMX Nordic 40 rose 0.61% to 2,617.28. Ericsson gained 2.9%, with Boliden and AstraZeneca also rising over 2%. SEB fell 1.6%. Traders now await Swedish PMI and inflation data, plus the upcoming U.S. payrolls report.
1 March 2026
············
AstraZeneca stock: Nasdaq-100 exit date nears as index flows and JPM conference loom

AstraZeneca stock: Nasdaq-100 exit date nears as index flows and JPM conference loom

AstraZeneca will be removed from the Nasdaq-100 on Jan. 20, replaced by Walmart, Nasdaq said Friday. AstraZeneca shares rose 0.28% in London and 0.68% in New York after the announcement. Index funds are expected to adjust holdings near the effective date, potentially increasing trading volume. AstraZeneca management is set to speak at the JPMorgan Healthcare Conference starting Monday.
11 January 2026
····
AstraZeneca stock set for Nasdaq-100 exit on Jan. 20 as Walmart takes its slot — what AZN investors watch next

AstraZeneca stock set for Nasdaq-100 exit on Jan. 20 as Walmart takes its slot — what AZN investors watch next

Nasdaq said Friday that Walmart will replace AstraZeneca in the Nasdaq-100 before trading opens Jan. 20. AstraZeneca’s U.S. shares closed at $94.65, up 0.68%, with volume near 6.1 million. Investors are watching AstraZeneca’s management talks at the J.P. Morgan Healthcare Conference Jan. 12–14 and its full-year results on Feb. 10.
10 January 2026
···
AstraZeneca (AZN) Stock Skyrockets: $50B U.S. Gamble, Trump Pricing Deal & Analyst Forecasts

AstraZeneca (AZN) Stock Skyrockets: $50B U.S. Gamble, Trump Pricing Deal & Analyst Forecasts

AstraZeneca shares traded near £127.82 ($85 ADR) on Oct. 10, 2025, close to a 52-week high after a U.S. NYSE listing and a $4.5 billion Virginia plant announcement. Market cap stands at $264 billion, with 2024 revenue of $54.1 billion, up 18%. The company agreed to provide U.S. Medicaid with its lowest global drug prices. Shares have rallied over 10% since late September.
11 October 2025
···
Market Record Rally Amid Shutdown: A Deep Dive into U.S. Stock Performance on 1 October 2025

Market Record Rally Amid Shutdown: A Deep Dive into U.S. Stock Performance on 1 October 2025

U.S. stocks closed at record highs despite a partial government shutdown, with the S&P 500 up 0.34% to 6,711.20 and the Dow rising 0.09% to 46,441.10. Health-care shares jumped after Pfizer and the White House struck a drug price deal, sending Biogen up 10.9%. The ADP report showed private-sector jobs fell by 32,000 in September, but investors bet on Fed rate cuts.
1 October 2025
·····

Stock Market Today

  • June 2026 ASX Penny Stocks to Watch Amid Market Uncertainty
    June 28, 2026, 10:27 PM EDT. As global tensions, including U.S.-Iran relations, influence markets, Australian investors eye ASX penny stocks for value and growth. Estrella Resources (ASX: ESR) explores minerals in Australia and Timor-Leste, operating pre-revenue with a market cap of A$53.05 million, debt-free but with limited cash runway. Leadership changes seek to bolster its Timor-Leste projects. Fleetwood Limited (ASX: FWD), valued at A$156.89 million, is exiting its RV segment to focus on modular buildings, reporting a remarkable 302.4% earnings increase despite restructuring costs. Debt-free with strong asset coverage, Fleetwood trades at a P/E of 8.5x but faces management experience challenges. These companies highlight the cautious optimism among traders for affordable growth opportunities in the new financial year.

Latest articles

Trump-era loan caps could open door for private lenders in grad school market

Trump-era loan caps could open door for private lenders in grad school market

29 June 2026
July 1 federal loan caps slash Grad PLUS access, forcing many graduate and professional students to seek private loans; Sallie Mae projects up to 70% origination growth over several years, while SoFi reports record student-loan volume—investors now face a real-time test of how much demand shifts to private lenders as federal limits hit.
IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

29 June 2026
IREN Limited (NASDAQ:IREN) plunged 21.3% to $47.21 over five straight down days despite announcing a record $50M+ annual Warriors jersey deal, as investors focused on the company’s not fully contracted $4.4B target ARR and high short interest at 19.74% of float, with Friday’s close near the lowest analyst target.
Go toTop